Melanoma CME

This activity is expired and is no longer available for CME credit.


Sequencing Targeted Therapy and Immunotherapy for Patients with Metastatic BRAFV600 Mutant Melanoma: How are We Going to Figure it Out?

Author(s)/Faculty: Michael B. Atkins, MD
Release Date: 11/12/2015Expiration Date: 11/11/2016
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Metastatic melanoma is one of the most challenging malignancies to treat. However, therapy for this cancer has been revolutionized by developments in targeted therapy and immunotherapy. This educational activity will review the therapeutic approach to patients with BRAFV600 mutant melanoma.